These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1369387)

  • 1. Multilocus DNA fingerprint analysis of cell banks: stability studies and culture identification in human B-lymphoblastoid and mammalian cell lines.
    Stacey GN; Bolton BJ; Morgan D; Clark SA; Doyle A
    Cytotechnology; 1992; 8(1):13-20. PubMed ID: 1369387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide fingerprinting as a means to identify and survey long-term cultured B cell hybridomas and T cell lines.
    Hampe J; Nürnberg P; Epplen C; Jahn S; Grunow R; Epplen JT
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):186-90. PubMed ID: 1335788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality control of cell banks using DNA fingerprinting.
    Stacey GN; Bolton BJ; Doyle A
    EXS; 1991; 58():361-70. PubMed ID: 1831163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
    Becker Y; Tabor E; Asher Y
    Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA fingerprinting--a valuable new technique for the characterisation of cell lines.
    Stacey G; Bolton B; Doyle A; Griffiths B
    Cytotechnology; 1992; 9(1-3):211-6. PubMed ID: 1369174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell growth effects of Epstein-Barr virus leader protein.
    Allan GJ; Inman GJ; Parker BD; Rowe DT; Farrell PJ
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1547-51. PubMed ID: 1318948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid method for starting a culture for the establishment of Epstein-Barr virus-transformed human lymphoblastoid cell lines.
    Fukushima Y; Ohashi H; Wakui K; Nishida T; Oh-ishi T
    Jpn J Hum Genet; 1992 Jun; 37(2):149-50. PubMed ID: 1327290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines.
    Liu X; Xu C; Duan Z
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of EBV-Infected Lymphoblastoid Cell Lines.
    Nagy N
    Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of specific immunoglobulin secretion by EBV-transformed lymphoblastoid cells and human-murine heterohybridomas.
    Glasky MS; Reading CL
    Hybridoma; 1989 Aug; 8(4):377-89. PubMed ID: 2550358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
    Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
    Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
    Chiorazzi N; Wasserman RL; Kunkel HG
    J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
    Lau YL; Shields JG; Levinsky RJ; Callard RE
    Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
    Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
    Wilson AD; Redchenko I; Williams NA; Morgan AJ
    Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.